Skip to main content

AIkido Pharma, Inc. (AIKI)

NASDAQ: AIKI · IEX Real-Time Price · USD
0.810
-0.011 (-1.39%)
After-hours:Sep 24, 2021 7:45 PM EDT
0.821
0.038 (4.90%)
At close: Sep 24, 4:00 PM
Market Cap73.66M
Revenue (ttm)9,000
Net Income (ttm)-7.01M
Shares Out89.60M
EPS (ttm)-0.13
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,421,014
Open0.772
Previous Close0.783
Day's Range0.765 - 0.833
52-Week Range0.466 - 2.550
Beta1.52
Analystsn/a
Price Target19.00 (+2,213.1%)
Est. Earnings DateNov 11, 2021

About AIKI

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus,...

IndustryBiotechnology
Founded1967
CEOAnthony Hayes
Employees4
Stock ExchangeNASDAQ
Ticker SymbolAIKI
Full Company Profile

Financial Performance

Financial Statements

News

Are Biotech Penny Stocks Worth Buying? Check These 3 Out

Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information ...

Other symbols:CLVSVIVE
6 days ago - PennyStocks

AIkido Pharma Secures Interest in Growing Tele-health Company

NEW YORK, Sept. 20, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company secured an early equity interest in tele-health company, Kerna Hea...

6 days ago - PRNewsWire

AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching

NEW YORK, Sept. 14, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today released the following shareholder update: Dear Shareholder, September is an opportune time t...

1 week ago - PRNewsWire

AIkido Provides Update on Use of Machine Learning in Drug Development Program

NEW YORK, Aug. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided and update on the use of Machine Learning in support of its antiviral platform with th...

1 month ago - PRNewsWire

Notice of Allowance Issued for Central Nervous System Peptide Technology

NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for appli...

1 month ago - PRNewsWire

AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland

NEW YORK, July 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update to the progress of its antiviral platform with the University of Maryland S...

2 months ago - PRNewsWire

AIkido Pharma to Attend the Alzheimer's Association International Conference

NEW YORK, July 13, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced it will attend the Alzheimer's Association International Conference in Denver, July ...

2 months ago - PRNewsWire

AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease

NEW YORK, June 23, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company has filed a provisional patent application for the use of ketamine ...

3 months ago - PRNewsWire

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

NEW YORK, June 4, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June...

3 months ago - PRNewsWire

AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash

New York, New York--(Newsfile Corp. - May 20, 2021) -  PCG Digital -- Anthony Hayes is an optimist, with good reason. The CEO of AIkido Pharmaceuticals (NASDAQ: AIKI), according to the company's Q1 repo...

4 months ago - Newsfile Corp

AIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of Clinical Oncology ("ASCO") Annual Mee...

NEW YORK, May 20, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Phase 1 testing data will be presented at the 2021 ASCO Annual Meeting June 4, 2...

4 months ago - PRNewsWire

AIKI Featured as Stock to Watch Ahead of Significant Key Milestones

New York, New York--(Newsfile Corp. - May 19, 2021) - PCG Digital -- Continuing the barrage of good-news announcements that began with its first quarter results and strong balance sheet reports, Alkido ...

4 months ago - Newsfile Corp

7 Reddit Penny Stocks Promising to Cure Cancer

These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on I...

4 months ago - InvestorPlace

AIkido Pharma Inc.: Invitation to the Q2 Virtual Investor Summit

New York, New York--(Newsfile Corp. - May 13, 2021) - AIkido Pharma Inc. (NASDAQ: AIKI) today announced that Darrell G. Dotson, Vice President and General Counsel will be attending the Q2 Virtual Invest...

4 months ago - Newsfile Corp

AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives

New York, New York--(Newsfile Corp. - May 13, 2021) - PCG Digital -- Things seem to be heating up for (NASDAQ: AIKI) with a near term potential catalyst quickly approaching this quarter and several othe...

4 months ago - Newsfile Corp

AIkido Pharma Inc. Announces First Quarter 2021 Results and Provides Corporate Update

NEW YORK, May 11, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") reported financial results for the first quarter ended March 31, 2021 and provided a corporate update...

4 months ago - PRNewsWire

Top Biotech Penny Stocks on Reddit? Check These 3 Out

Biotech penny stocks are back in focus; should these 3 be on your watchlist? The post Top Biotech Penny Stocks on Reddit?

Other symbols:ATOSDFFN
4 months ago - PennyStocks

AIkido Pharma Announces Inventor and Scientist Dr. Matthew Frieman Joins Scientific Advisory Board

NEW YORK, April 26, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company's Scientific Advisory Board. "Dr. F...

5 months ago - PRNewsWire

4 Reddit Penny Stocks To Buy On Robinhood For Under $1 Right Now

Penny stocks on Robinhood are a big focus for Reddit traders in April The post 4 Reddit Penny Stocks To Buy On Robinhood For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Inf...

Other symbols:BBIKIQOGEN
5 months ago - PennyStocks

Biotech Penny Stocks To Buy? 3 to Watch Under $5

Biotech stocks are more popular than ever; here are 3 to watch under $5 The post Biotech Penny Stocks To Buy? 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols:BBIBIOL
5 months ago - PennyStocks

AIkido Pharma Announces Withdrawal of S-1 Registration Statement

NEW YORK, April 22, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company has withdrawn its S-1 Registration Statement that was previously f...

5 months ago - PRNewsWire

4 Biotech Penny Stocks To Watch That Are Heating Up This Month

Biotech penny stocks are all the rage; should you check these four out? The post 4 Biotech Penny Stocks To Watch That Are Heating Up This Month appeared first on Penny Stocks to Buy, Picks, News and Inf...

Other symbols:ITRMOVIDTTOO
5 months ago - PennyStocks

AIkido Pharma Notes Advancement in Radiopharmaceutical Research

NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conduc...

5 months ago - PRNewsWire

Aikido Secures Sublicense For Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients

Aikido Pharma Inc (NASDAQ: AIKI) has been granted an exclusive sublicense to technology related to the use of the central nervous system (CNS) homing peptides to treat neuroinflammatory disease in cance...

5 months ago - Benzinga

AIkido Granted Sublicense to Technology for Targeted Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients

NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of...

5 months ago - PRNewsWire